Drugs / TS-022
last change Oct 2010 re-read 3 minutes ago

TS-022

Developed for
atopic eczema
Investigated by
Taisho Pharmaceutical R&D Inc.

Trials 1

2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00914186 Jun 2009 → May 2010 atopic eczema Taisho Pharmaceutical R&D Inc. Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as TS-022 “Study of TS-022 in Adult Patients With Atopic Dermatitis With Pruritus (POC)” NCT00914186 ↗
Route Topical “twice-daily topical application” NCT00914186 ↗